Clinical Trial
Cefuroxime in severe respiratory infections: a double-blind comparison of two doses
- PMID: 400110
Item in Clipboard
Clinical Trial
Cefuroxime in severe respiratory infections: a double-blind comparison of two doses
Br J Dis Chest.
1979 Oct.
Abstract
Cefuroxime, a new cephalosporin, was given in doses of 750 mg and 1000 mg three times daily for 10 days to 99 patients in a double-blind comparison. Patients were moderately or severely ill with exacerbations of chronic bronchitis, often accompanied by pneumonia. Both doses were equally efficacious in improving the clinical state and sputum purulence and in maintaining the improvement.
Similar articles
-
Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.Clin Ther. 1989 May-Jun;11(3):304-14. Clin Ther. 1989. PMID: 2663160 Clinical Trial.
-
Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.Int J Clin Pract. 1998 Jul-Aug;52(5):289-97. Int J Clin Pract. 1998. PMID: 9796558 Clinical Trial.
-
Experience with cefuroxime in 190 patients with severe respiratory infections.Chemotherapy. 1980;26(3):212-7. doi: 10.1159/000237907. Chemotherapy. 1980. PMID: 7363715
-
[Parenteral cephalosporins for the treatment of lower respiratory tract infections].Infection. 1993;21 Suppl 1:S28-34. doi: 10.1007/BF01710341. Infection. 1993. PMID: 8314290 Review. German.
-
[Prevention of postoperative infections by administration of a single dose of antibiotic: cefuroxime (Curoxime) in "flash" antibiotic prophylaxis].Ann Chir. 1986 Dec;40(9):687-91. Ann Chir. 1986. PMID: 3296927 Review. French. No abstract available.
Cited by
-
Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.Cochrane Database Syst Rev. 2015 Aug 13;2015(8):CD001392. doi: 10.1002/14651858.CD001392.pub3. Cochrane Database Syst Rev. 2015. PMID: 26270620 Free PMC article.